Level Four Advisory Services’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Level Four Advisory Services’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-12,002	Closed	-$188K	–	534
2019 Q1	$188K	Sell	12,002 -1,985	-14%	-$35K	0.02%	489
2018 Q4	$216K	Sell	13,987 -6,477	-32%	-$133K	0.03%	465
2018 Q3	$441K	Buy	20,464 +105	+0.5%	+$2.44K	0.05%	366
2018 Q2	$495K	Buy	20,359 +12	+0.1%	+$245	0.04%	383
2018 Q1	$348K	Buy	20,347 +1,850	+10%	+$36.1K	0.03%	414
2017 Q4	$351K	Buy	18,497 +3,364	+22%	+$50.6K	0.03%	419
2017 Q3	$266K	Buy	+15,133	New	+$340K	0.02%	442

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Level Four Advisory Services's TEVA Position: Q2 2019 in Review

Level Four Advisory Services sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2019, closing a stake of 12,002 shares — an estimated $188K sold.

Level Four Advisory Services first reported a position in TEVA in Q3 2017 and held it in 7 quarters. The position peaked at $495K in Q2 2018. 452 funds tracked by Wall St. Rank hold TEVA as of Q2 2019.

Level Four Advisory Services reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2019 after selling out during the quarter.
Level Four Advisory Services sold 12,002 Teva Pharmaceutical Industries Limited shares in Q2 2019, an estimated $188K.
Level Four Advisory Services first reported a position in Teva Pharmaceutical Industries Limited in Q3 2017 and held it in 7 quarters.
Level Four Advisory Services's Teva Pharmaceutical Industries Limited position peaked at $495K in Q2 2018.
452 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2019.

Based on Level Four Advisory Services's 13F filing for Q2 2019, filed 14 Aug 2019.